Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
letter
. 1988 Apr;81(4):242. doi: 10.1177/014107688808100424

Economic aspects of beta-blocker therapy following myocardial infarction.

G Olsson
PMCID: PMC1291557  PMID: 2897465

Full text

PDF

Page 242

242

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Olsson G., Levin L. A., Rehnqvist N. Economic consequences of postinfarction prophylaxis with beta blockers: cost effectiveness of metoprolol. Br Med J (Clin Res Ed) 1987 Feb 7;294(6568):339–342. doi: 10.1136/bmj.294.6568.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Olsson G., Lubsen J., van Es G. A., Rehnqvist N. Quality of life after myocardial infarction: effect of long term metoprolol on mortality and morbidity. Br Med J (Clin Res Ed) 1986 Jun 7;292(6534):1491–1493. doi: 10.1136/bmj.292.6534.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES